Ritanserin
SIGMA/R103 - powder
Synonym: 6-
CAS Number: 87051-43-2
Empirical Formula (Hill Notation): C27H25F2N3OS
Molecular Weight: 477.57
MDL Number: MFCD00069341
Linear Formula: C27H25F2N3OS
Product Type: Chemical
| color | white |
| form | powder |
| InChI | 1S/C27H25F2N3OS/c1-18-24( |
| InChI key | JUQLTPCYUFPYKE-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | CC1=C(CCN2CCC(CC2)=C(c3 |
| solubility | 2-hydroxypropyl-β-cyclode |
| dilute aqueous base: insoluble | |
| DMSO: >10.1 mg/mL | |
| H2O: insoluble | |
| methanol: >10 mg/mL |
| Application: | Ritanserin has been used in behavioral testing and as a serotonin 2A receptor (5-HT2A)-receptor antagonist. |
| Biochem/physiol Actions: | Potent 5-HT2A serotonin receptor antagonist/inverse agonist that crosses the blood-brain barrier. |
| Biochem/physiol Actions: | Ritanserin is a potent serotonin 2A receptor (5-HT2A) serotonin receptor antagonist/inverse agonist, which crosses the blood-brain barrier. It modulates 5-HT2A receptors and has been suggested to have antiparkinsonian effect. Ritanserin also impacts schizophrenia by modulating mood, cognition and negative symptoms. |
| Packaging: | 25, 100, 250 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 22-26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |


